Nurexone Biologic Inc (NRX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 4,018 | 1,562 | 2,214 |
| Receivables | 373 | 186 | 517 |
| Other current assets | 17 | 19 | 19 |
| TOTAL | $4,408 | $1,767 | $2,836 |
| Non-Current Assets | |||
| PPE Net | 111 | N/A | 0 |
| TOTAL | $111 | $0 | $0 |
| Total Assets | $4,519 | $1,767 | $2,836 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 1,081 | 1,043 |
| Accrued Expenses | 167 | N/A | 183 |
| Other current liabilities | N/A | 130 | 242 |
| TOTAL | $660 | $1,578 | $1,631 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 72 | 63 | 28 |
| TOTAL | $109 | $63 | $28 |
| Total Liabilities | $769 | $1,641 | $1,659 |
| Shareholders' Equity | |||
| Common Shares | 75 | 52 | 0 |
| Retained earnings | -8,363 | -4,564 | -2,249 |
| Other shareholders' equity | 1,234 | 293 | 169 |
| TOTAL | $3,750 | $126 | $1,177 |
| Total Liabilities And Equity | $4,519 | $1,767 | $2,836 |